Supply Issues Becton Dickinson BD BACTEC™ Blood Culture Bottles HFL7393, HFL8901, KWL85002 and KWL85003 (ICN 2462)

• The supply issue with BD BACTEC™ Blood Culture Bottle products from Becton Dickinson is continuing.
• Four product codes remain affected and are still available to order on an intermittent supply basis:
  • HFL7393 – Media Bd Bactec Plus Aerobic F Medium Plastic
  • HFL8901 – Media Bd Bactec lytic 10 anaerobic F Medium Plastic
  • KWL85002 – Media Peds Plus
  • KWL85003 – Media Plus Anaerobic.
• The affected products remain threshold managed by the supplier, as they are subject to their Protect Demand Management.
• Becton Dickinson have steadily improved shipments by 50% since May 2024.
• Becton Dickinson have increased shipment schedules from the Vial manufacturer to the Becton Dickinson manufacturing plants from 2x per week to 3-4x per week, enabling optimised product production to expedite delivery to customers.
• Based on actions taken, Becton Dickinson anticipates that supply will continue to improve over coming months and further updates will be provided until inventory levels are fully recovered.
• Unfortunately, there are no alternatives available due to the capital equipment (analysers) in situ within a pathology laboratory.
  • Alternatives would only be suitable if the capital equipment needs replacement. Blood Culture bottles are captive to the capital equipment in place.
  • To consider alternative suppliers’ significant investment will be needed as well as a period of training and quality assurance. Suppliers are reporting a 6 – 8-week lead time for replacement capital.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• We currently do not have a resolution date and will update this ICN when we have further information

• The supply issue with BD BACTEC™ Blood Culture Bottle products from Becton Dickinson is continuing.
• Four product codes remain affected and are still available to order on an intermittent supply basis:
  • HFL7393 – Media Bd Bactec Plus Aerobic F Medium Plastic
  • HFL8901 – Media Bd Bactec lytic 10 anaerobic F Medium Plastic
  • KWL85002 – Media Peds Plus
  • KWL85003 – Media Plus Anaerobic.
• These products remain threshold managed by the supplier Beckton Dickinson, so they are subject to their Protect Demand Management.
• Unfortunately, there are no alternatives available due to the capital equipment (analysers) in situ within a pathology laboratory.
• • Alternatives would only be suitable if the capital equipment needs replacement. Blood Culture Bottles are captive to the capital equipment in place.
  • To consider alternative suppliers, significant investment will be needed as well as a period of training and quality assurance.
  • Suppliers are reporting a 6 – 8-week lead time for replacement capital.
• The supply issue is anticipated to be resolved by 10 October 2024.

Change:

• The supplier Becton Dickinson has informed us of a supply issue with its BD BACTEC™ Blood Culture Bottle products.
• The four product codes affected are:
  • HFL7393 – Media Bd Bactec Plus Aerobic F Medium Plastic
  • HFL8901 – Media Bd Bactec lytic 10 anaerobic F Medium Plastic
  • KWL85002 – Media Peds Plus
  • KWL85003 – Media Plus Anaerobic.
• The supply issue is due to supplier manufacturing issues.
• Issues were reported at the end of 2023 due to poor weather impacting the supply of the plastic bottle the reagent is held in. This has meant Becton Dickinson had a break in manufacturing which has impacted their backorder along with increased demand over the winter period.
• Due to this ongoing supply issue these products are now being threshold managed by the supplier Beckton Dickinson, so they are subject to their Protect Demand Management.

Impact:          

• The affected codes are still available to order on intermittent supply basis.
• Unfortunately, there are no alternatives available due to the capital equipment (analysers) in situ within a pathology laboratory.
  • Alternatives would only be suitable if the capital equipment needs replacement. Blood Culture bottles are captive to the capital equipment in place.
  • To consider alternative suppliers’ significant investment will be needed as well as a period of training and quality assurance. Suppliers are reporting a 6 – 8-week lead time for replacement capital.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is anticipated to be resolved by 31 May 2024.
• Becton Dickinson are working with customers to do local stock takes to continually monitor stock levels and ensure accurate allocations and continuous supply.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product codes.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.